vs
Side-by-side financial comparison of C & F FINANCIAL CORP (CFFI) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $35.9M, roughly 1.1× C & F FINANCIAL CORP). C & F FINANCIAL CORP runs the higher net margin — 18.7% vs -161.8%, a 180.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 12.0%). C & F FINANCIAL CORP produced more free cash flow last quarter ($22.2M vs $-71.3M).
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CFFI vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.9M | $38.3M |
| Net Profit | $6.7M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 22.6% | -169.0% |
| Net Margin | 18.7% | -161.8% |
| Revenue YoY | 12.0% | 407.0% |
| Net Profit YoY | 11.0% | -4.7% |
| EPS (diluted) | $2.08 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.9M | $38.3M | ||
| Q3 25 | $36.0M | $32.1M | ||
| Q2 25 | $36.4M | $26.4M | ||
| Q1 25 | $32.6M | $16.5M | ||
| Q4 24 | $32.0M | $7.6M | ||
| Q3 24 | $33.5M | $6.1M | ||
| Q2 24 | $31.2M | — | ||
| Q1 24 | $30.6M | — |
| Q4 25 | $6.7M | $-61.9M | ||
| Q3 25 | $7.1M | $-67.3M | ||
| Q2 25 | $7.7M | $-92.6M | ||
| Q1 25 | $5.4M | $-129.6M | ||
| Q4 24 | $6.0M | $-59.2M | ||
| Q3 24 | $5.4M | $-85.7M | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 22.6% | -169.0% | ||
| Q3 25 | 24.5% | -173.5% | ||
| Q2 25 | 26.5% | -269.8% | ||
| Q1 25 | 20.0% | -390.1% | ||
| Q4 24 | 22.6% | -919.0% | ||
| Q3 24 | 19.9% | -1314.3% | ||
| Q2 24 | 20.0% | — | ||
| Q1 24 | 13.1% | — |
| Q4 25 | 18.7% | -161.8% | ||
| Q3 25 | 19.6% | -209.8% | ||
| Q2 25 | 21.2% | -350.3% | ||
| Q1 25 | 16.5% | -784.9% | ||
| Q4 24 | 18.8% | -783.4% | ||
| Q3 24 | 16.1% | -1404.0% | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 11.1% | — |
| Q4 25 | $2.08 | $-0.06 | ||
| Q3 25 | $2.18 | $-0.07 | ||
| Q2 25 | $2.37 | $-0.10 | ||
| Q1 25 | $1.66 | $-0.15 | ||
| Q4 24 | $1.85 | $-0.08 | ||
| Q3 24 | $1.65 | $-0.14 | ||
| Q2 24 | $1.50 | — | ||
| Q1 24 | $1.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $261.8M | $-500.5M |
| Total Assets | $2.8B | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $242.8M | ||
| Q3 25 | — | $257.8M | ||
| Q2 25 | — | $153.7M | ||
| Q1 25 | — | $61.6M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $261.8M | $-500.5M | ||
| Q3 25 | $253.3M | $-524.3M | ||
| Q2 25 | $240.3M | $-570.7M | ||
| Q1 25 | $234.6M | $-591.4M | ||
| Q4 24 | $226.4M | $-489.1M | ||
| Q3 24 | $227.3M | $-745.1M | ||
| Q2 24 | $218.5M | — | ||
| Q1 24 | $216.3M | — |
| Q4 25 | $2.8B | $501.9M | ||
| Q3 25 | $2.7B | $519.0M | ||
| Q2 25 | $2.7B | $402.1M | ||
| Q1 25 | $2.6B | $303.8M | ||
| Q4 24 | $2.6B | $382.9M | ||
| Q3 24 | $2.6B | $364.6M | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.5M | $-70.4M |
| Free Cash FlowOCF − Capex | $22.2M | $-71.3M |
| FCF MarginFCF / Revenue | 61.8% | -186.2% |
| Capex IntensityCapex / Revenue | 6.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 3.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $42.8M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.5M | $-70.4M | ||
| Q3 25 | $23.4M | $-68.9M | ||
| Q2 25 | $-4.4M | $-79.7M | ||
| Q1 25 | $3.2M | $-85.9M | ||
| Q4 24 | $36.8M | $-85.1M | ||
| Q3 24 | $404.0K | $-98.8M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $895.0K | — |
| Q4 25 | $22.2M | $-71.3M | ||
| Q3 25 | $22.7M | $-69.6M | ||
| Q2 25 | $-5.0M | $-80.8M | ||
| Q1 25 | $2.9M | $-87.0M | ||
| Q4 24 | $33.3M | $-87.3M | ||
| Q3 24 | $-1.6M | $-101.6M | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $410.0K | — |
| Q4 25 | 61.8% | -186.2% | ||
| Q3 25 | 63.0% | -217.2% | ||
| Q2 25 | -13.6% | -305.9% | ||
| Q1 25 | 9.0% | -526.9% | ||
| Q4 24 | 103.8% | -1155.4% | ||
| Q3 24 | -4.9% | -1663.2% | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 6.5% | 2.4% | ||
| Q3 25 | 2.1% | 2.3% | ||
| Q2 25 | 1.6% | 4.1% | ||
| Q1 25 | 0.8% | 6.8% | ||
| Q4 24 | 10.9% | 28.0% | ||
| Q3 24 | 6.1% | 45.7% | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 3.65× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | -0.57× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 6.09× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFFI
| Community Banking | $25.9M | 72% |
| Consumer Finance Segment | $7.0M | 19% |
| Mortgage Banking Segment | $1.9M | 5% |
| Other | $1.1M | 3% |
IBRX
Segment breakdown not available.
